China Biologic Products Inc. (NASDAQ:CBPO)

Sunday, June 21, 2015 | Web News
ITEM 7.01 REGULATION FD DISCLOSURE. On June 15, 2015, China Biologic Products, Inc. (the “Company”...
Friday, June 12, 2015 | Web News
CHINA BIOLOGIC PRODUCTS, INC. CALCULATION OF REGISTRATION FEE >
Wednesday, June 10, 2015 | Web News
BEIJING, June 10, 2015 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the...

At least one FIE exists in the corporate structure

China Biologic Products, Inc., through its indirect majority-owned subsidiary, Shandong Taibang, is currently the only plasma-based biopharmaceutical company approved by the government of Shandong Province, the second largest province with a population of 93 million. The company is engaged primarily in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China.

Web site: http://www.ctbb.com.cn/

Last updated March 17, 2008